|
Sign In to gain access to subscriptions and/or personal tools.
|
The Dichotomy of NMDA Receptor Signaling
Sofia Papadia
Centre for Neuroscience Research, University of Edinburgh, Edinburgh, United Kingdom
Giles E. Hardingham
Centre for Neuroscience Research, University of Edinburgh, Edinburgh, United Kingdom, Giles.Hardingham{at}ed.ac.uk
The N-methyl-D-aspartate (NMDA) subtype of ionotropic glutamate receptors plays a Jekyll and Hyde role in the mammalian central nervous system. In pathological scenarios such as ischemia, Ca2+ influx through the NMDA receptor is a key mediator of cell death. However, physiological levels of NMDA-receptor activity can promote neuronal survival and resistance to trauma and play important roles in synaptic plasticity and transmission. This dichotomy may explain the poor tolerance and efficacy of NMDA-receptor antagonists in clinical trials for excitotoxic trauma. There is a growing understanding of the signaling events that mediate the opposing effects of NMDA-receptor activity and the factors that determine whether an episode of NMDA-receptor activity will promote survival or death. This knowledge may lead to therapeutic strategies that enable the selective blockade of prodeath signaling cassettes while sparing physiological signaling to survival and plasticity. NEUROSCIENTIST 13(6):572—579, 2007. DOI: 10.1177/1073858407305833
Key Words: Apoptosis Necrosis Neuroprotection Stroke NMDA receptor Extrasynaptic Synaptic activity CREB Akt Calcium
The Neuroscientist, Vol. 13, No. 6,
572-579 (2007)
DOI: 10.1177/10738584070130060401

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Deng and S. C. Thomson
Renal NMDA receptors independently stimulate proximal reabsorption and glomerular filtration
Am J Physiol Renal Physiol,
May 1, 2009;
296(5):
F976 - F982.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Y. Heng, P. J. Detloff, P. L. Wang, J. Z. Tsien, and R. L. Albin
In Vivo Evidence for NMDA Receptor-Mediated Excitotoxicity in a Murine Genetic Model of Huntington Disease
J. Neurosci.,
March 11, 2009;
29(10):
3200 - 3205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. T. Crews and K. Nixon
Mechanisms of Neurodegeneration and Regeneration in Alcoholism
Alcohol Alcohol.,
March 1, 2009;
44(2):
115 - 127.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. R. Joshi, N.-P. Wu, V. M. Andre, D. M. Cummings, C. Cepeda, J. A. Joyce, J. B. Carroll, B. R. Leavitt, M. R. Hayden, M. S. Levine, et al.
Age-Dependent Alterations of Corticostriatal Activity in the YAC128 Mouse Model of Huntington Disease
J. Neurosci.,
February 25, 2009;
29(8):
2414 - 2427.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Cowan, M. M. Y. Fan, J. Fan, J. Shehadeh, L. Y. J. Zhang, R. K. Graham, M. R. Hayden, and L. A. Raymond
Polyglutamine-Modulated Striatal Calpain Activity in YAC Transgenic Huntington Disease Mouse Model: Impact on NMDA Receptor Function and Toxicity
J. Neurosci.,
November 26, 2008;
28(48):
12725 - 12735.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. X. Soriano, M.-A. Martel, S. Papadia, A. Vaslin, P. Baxter, C. Rickman, J. Forder, M. Tymianski, R. Duncan, M. Aarts, et al.
Specific Targeting of Pro-Death NMDA Receptor Signals with Differing Reliance on the NR2B PDZ Ligand
J. Neurosci.,
October 15, 2008;
28(42):
10696 - 10710.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|